This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Johns Hopkins University, Lieber Institute, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022-2026
Title: Marikki K Laiho: Innovator in Cancer Risk Assessment and Treatment
Introduction
Marikki K Laiho is a notable inventor based in Kauniainen, Finland. He has made significant contributions to the field of cancer research, particularly in assessing cancer risk and developing treatment methods. With a total of 3 patents, his work has the potential to impact many lives.
Latest Patents
Laiho's latest patents focus on materials and methods for assessing cancer risk and treating cancer. These documents detail innovative approaches for determining whether subjects, particularly those with autoimmune diseases, possess antibodies that indicate a lower or higher risk of cancer. Furthermore, the patents provide methods for treating individuals identified as having a higher risk of cancer, showcasing Laiho's commitment to advancing medical science.
Career Highlights
Throughout his career, Marikki K Laiho has worked with prestigious institutions, including Johns Hopkins University. His research has been instrumental in developing new methodologies that enhance our understanding of cancer risk and treatment options. His dedication to innovation in this critical field is evident in his patent filings and research contributions.
Collaborations
Laiho has collaborated with esteemed colleagues such as Antony Rosen and Takeru Igusa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer research.
Conclusion
Marikki K Laiho's work in cancer risk assessment and treatment exemplifies the spirit of innovation in medical research. His patents and collaborations highlight his significant contributions to the field, paving the way for future advancements in cancer care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile